Rosalind Advisors, Inc.

Holdings History for FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)

Symbol: FENC on Nasdaq
Investment type: Equity / Common stock, no par value (the "Shares")
Latest Disclosed Shares Owned: 2,746,840 shares
Security Ownership %: 9.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Rosalind Advisors, Inc. ownership in FENNEC PHARMACEUTICALS INC. Common stock, no par value (the "Shares") (FENC)

11 Feb 2026 - Rosalind Advisors, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,746,840 shares of FENNEC PHARMACEUTICALS INC. Common stock, no par value (the "Shares") (FENC). This represents 9.8% ownership of the company. In their previous filing dated 13 Nov 2025, Rosalind Advisors, Inc. had reported owning 2,076,840 shares, indicating an increase of +32%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Rosalind Advisors, Inc.	9.8%	+29%	$21,095,731	2,746,840	+670,000	+32%	$7.68	13G/A	31 Dec 2025	11 Feb 2026, 13:58
Rosalind Advisors, Inc.	7.5%		$19,439,222	2,076,840			$9.36	13G	30 Sep 2025	13 Nov 2025, 16:08

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	7.7%	+1.6%	$20,124,012	2,613,508	+536,668	+26%	$7.70	Q4 2025
30 Sep 2025	7.1%	+0.11%	$19,439,222	2,076,840	+31,196	+1.5%	$9.36	Q3 2025
30 Jun 2025	8.2%	+1.1%	$16,978,845	2,045,644	+262,800	+15%	$8.30	Q2 2025
31 Mar 2025	5.3%	+1.6%	$10,857,520	1,782,844	+522,968		$6.09	Q1 2025
31 Dec 2024	4.3%	+4.3%	$7,962,416	1,259,876	+1,259,876	NEW	$6.32	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.